Showing results (221-230 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|November 29, 2002
Effects of angiotensin receptor blockade on haemodynamics and gene expression after myocardial infarctionAndrey K Gurevich, Sandor A Falk, Raphael A Nemenoff, et al.Drugs in R&D|November 24, 1999
Neuroprotection in acute ischaemic stroke. Current status and future potentialH L Lutsep, W M ClarkDrugs in R&D|November 24, 1999
Promising new agents in osteoporosisJ Y Reginster, Y Henrotin, C GossetDrugs in R&D|November 24, 1999
Novel neurohormonal modulators in cardiovascular disorders. The therapeutic potential of endopeptidase inhibitorsM Kentsch, W OtterDrugs in R&D|November 24, 1999
GP IIb/IIIa antagonists. Clinical experience and potential uses in cardiologyN S KleimanDrugs in R&D|May 11, 2002
Tolterodine: selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteersChristopher R Chapple, Lisbeth NilvebrantDrugs in R&D|January 9, 2003
Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illnessMichael W Simon, Douglas N Fish, Robert G DeeterDrugs in R&D|May 22, 2003
Abarelix: abarelix-depot-F, abarelix-depot-M, abarelix-L, PPI 149, R 3827Pageof 89